Treating Prostate Tumors with Precision Radiation on the CyberKnife S7 System For Clinicians
Treating Prostate Tumors with Precision Radiation on the CyberKnife S7 System For Clinicians
Prostate Cancer Treatment Information Guide
Learn how the CyberKnife® System can provide clinically proven, non-invasive, non-surgical and pain-free treatment.
Prostate Cancer Infographic Everything You Need To Know About Prostate Cancer
Prostate Cancer Infographic Everything You Need To Know About Prostate Cancer
Treating Prostate Tumors with Precision Radiation on the Radixact® System with Synchrony
Short Version Radixact® with Synchrony Prostate Animation
SMART QA: XACTLY Radixact® System QA Packages
Accuray is pleased to offer quality assurance (QA) packages for the Radixact® Treatment Delivery System to support commissioning and routine procedures required for maintaining proper system functionality.
Synchrony Infographic Motion Synchronization No-Tradeoff Radiation Therapy
Synchrony Infographic Motion Synchronization No-Tradeoff Radiation Therapy
Update on Phase 3 Randomized PACE Trial Data with Dr. Nicholas van As
Update on Phase 3 Randomized PACE Trial Data with Dr. Nicholas van As Phase 3 Randomized Trial Data shows SBRT has similar acute safety profile to conventional radiation therapy in patients with localized prostate cancer.
CyberKnife® Prostate Cancer Patient Experience
Watch this patient testimonial on the CyberKnife System treatment for Prostate Cancer
CYBERKNIFE® SYSTEM PROSTATE SBRT LARGEST CLINICAL STUDIES TO DATE
Read about two large prospective, multi-institutional and CyberKnife® System only clinical studies report excellent clinical outcomes at
five years post-treatment.
Mike “Bing” Crosby CyberKnife® Treatment
See how CyberKnife aided in effectively treating Mike “Bing” Crosby for prostate cancer.
PreciseART® Adaptive Radiation Therapy Software
Read about dose monitoring, re-planning, and delivery verification.
Prostate Advances in Comparative Evidence (PACE)
This study is an international multicenter randomized study of organ confined low and intermediate risk prostate cancer and is composed of two parallel randomization schemes based on applicability of surgery as a treatment for the patient. Patients for whom surgery is a consideration are randomized to either laparoscopic or da Vinci prostatectomy or CyberKnife prostate […]
Dosimetric Analysis of Treatment of Prostate Cancer
The TomoTherapy System offers a more favorable dose distribution to the bladder and rectum, as well as improved target homogeneity.
